INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/05/2026
Back to search
Official data from USPTO
GP PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
03/06/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
04/24/2017
Registration date
04/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/20/2024
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Barcelona, ES
Examiner
DINALLO, KEVIN M
Current location
Historical data usage
Mark description
The brand consists of the terms "GP PHARM" which appear below a design comprising three circles, one above another with a third circle to the left of the other two on an intermediate level.
Holders and representatives
Holders
GP Pharm S.A.
Representatives
Elizabeth Lee D'Amore Lucas & Mercanti, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in the cosmetic and pharmaceutical industries for human use
Class 5
House mark for pharmaceutical preparations other than veterinary preparations; Sanitary products for medical purposessterilizing preparations and antibacterial preparations; Dietetic substances for medical usedietetic foods adapted for medical use; Food for babies; Medical plastersbeing material for dressingsmedical dressingsbandagesgauzesadhesive bandstapes; Material for dental fillings and dental impressions; Disinfectants; herbicides; pharmaceutical preparations and substances for use in urologyoncology and gynecology
Class 42
Scientific and technological servicesas well as research and design services relating theretoscientific research for medical purposes in the field of urologyoncologygynecologycardiologyneurologygastroenterologyendocrinologyimmunologyrheumatologyophthalmologybiotechnologyanti-cancer treatmentschemotherapyhormonal therapiestreatment of pain and inflammationtreatment of muscular disorderstreatment of metabolic disorders and active peptides for medical use; Pharmaceutical research services; Biological research and medical research; Clinical research in the field of urologyoncologygynecologycardiologyneurologygastroenterologyendocrinologyimmunologyrheumatologyophthalmologybiotechnologychemotherapyhormonal therapiesanalgesiaanti-inflammatory compoundsmuscular disordersmetabolic disorders and active peptides for medical use
Publications
History of USPTO decisions and trademark events.
52 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/13/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
01/13/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/20/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/20/2024
71AG
REGISTERED-SEC.71 ACCEPTED
11/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/18/2024
ES71
TEAS SECTION 71 RECEIVED
03/27/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/03/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/06/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/18/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
08/29/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/14/2018
FIMP
FINAL DISPOSITION PROCESSED
07/14/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/03/2018
GPNX
NOTIFICATION PROCESSED BY IB
02/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2018
PUBO
PUBLISHED FOR OPPOSITION
01/16/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/09/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/09/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/21/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
11/08/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/08/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
11/08/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2017
ALIE
ASSIGNED TO LIE
11/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2017
RFNT
REFUSAL PROCESSED BY IB
10/21/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/29/2017
RFRR
REFUSAL PROCESSED BY MPU
09/28/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/26/2017
MAFR
APPLICATION FILING RECEIPT MAILED
09/26/2017
CNRT
NON-FINAL ACTION WRITTEN
09/25/2017
DOCK
ASSIGNED TO EXAMINER
09/22/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/21/2017
Continuous trademark protection
Get notified about every new filing that threatens GP PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.